CATALAYER NEWS

Earnings roundup: Amgen vs. FDA, Pfizer’s defense and Merck’s $70B-in-sales plan - BioPharma Dive

Source: BioPharma Dive · 2026-02-04

Full article text is available in the Catalayer news terminal.

MORE FROM BIOPHARMA DIVE
Argenx to acquire Forte in $2.2B deal for ‘differentiated’ immune drug
2026-07-28
RELATED ON CATALAYER
Mentioned Tickers
$PFE · Pfizer$MRK · Merck$AMGN · Amgen
Related Topics
Earnings Season NewsBiotech & FDA News
RELATED MARKETS
Prediction Markets
New Rihanna Album before GTA VI?50%New Playboi Carti Album before GTA VI?50%Will Jesus Christ return before GTA VI?50%
Open Catalayer terminal for live tracking →